MedPath

Study of Prevention of Postoperative Delirum to Reduce Incidence of Postoperative Cognitive Dysfunction

Not Applicable
Completed
Conditions
Postoperative Delirium
Postoperative Cognitive Dysfunction
Interventions
Other: monitoring and non-medical prophylaxis of delirium
Registration Number
NCT03060174
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Brief Summary

Postoperative cognitive dysfunction describes a condition where cognitive functions such as attention, perception, concentration, learning, abstract thinking and problem solving are impaired postoperatively. These changes can be resolved after weeks and months, but in some cases may be permanent.

The aetiology is multifactorial. One risk factor for developing POCD is the occurrence of postoperative delirium.

A total of 638 consecutive patients will be enrolled in the study. Patients will be followed up at 7 days, 3 months and 1 year postoperatively. The cognitive function will be tested and compared to tests done before surgery. Postoperatively (from the day of operation until the 7th day and except of day 6) the grade of sedation; agitation; signs of delirium; pain; cardiac; respiratory; renal and infectious complications will be recorded.

As possible influencing factors, the investigators will document diagnosed depression; comorbidities; intraoperative blood loss; length of hospital stay; 1-year-mortality; number of operations/anaesthetics undergone after the initial operation.

Parameters that could trigger either depressive symptoms, neurocognitive dysfunction, anxiety, fatigue or lack of concentration will be recorded. These include: anaemia, hypercalcaemia, thyroidal gland hormones, electrolytes, creatinine, urea, glomerular filtration rate, cortisone therapy and adrenal cortical insufficiency.

Detailed Description

The methods include a neuropsychological test battery: TAP 2.3 (attention), Trail Making Test (TMT )A+B (attention), Digit span (memory), (Visual Learning and Memory Test (VLMT) (memory), Regensburgerwortfluessigkeitstest/fluency (RWT) subtests (executive function), Mehrfach-Wortschatz-Intelligenztest/vocabulary (MWT-B) (premorbid IQ).

Other measures are Hospital Anxiety and Depression Scale (HADS-D) (depressive symptoms and anxiety), Mini Mental State Examination (MMSE) 2 (dementia), Confusion Assessment Method (CAM-ICU) (delirium), Richmond Agitation and Sedation Scale (RASS) (sedation and agitation), Numeric Rating Scale (NRS) (pain) and Short Form Health Survey (SF-12) (health related quality of life).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
638
Inclusion Criteria
  • Age > 60 years
  • Cardiac surgery (on-pump/off-pump, standard/minimal invasive)
  • Written informed patient's consent
Exclusion Criteria
  • Non-German speaking or not their first language
  • Illiteracy
  • Mental disability
  • Non-corrigible vision impairment
  • Non-corrigible hearing impairment
  • Illegal substance abuse (current or past history)
  • Alcohol abuse (current or past history)
  • Chronic benzodiazepine use
  • Psychosis (current or past history)
  • Parkinson Disease
  • Dementia
  • Multiple sclerosis
  • Epilepsy (current or past history)
  • Cerebral tumor (current or past history)
  • Apoplexy or intracranial bleeding (current or past history)
  • Severe traumatic brain injury (current or past history)
  • Severe liver disease (Child Pugh B, C, liver insufficiency)
  • Severe kidney disease with dialysis
  • Mini Mental Status Examination < 24 points

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
monitoring and non-medical prophylaxis of deliriummonitoring and non-medical prophylaxis of deliriumThe treatment group will receive monitoring and prophylaxis of delirium. The study arm designed to prevent delirium incorporates reorientation (watches, calendar, family photos, use of hearing aids, glasses and dentures, cognitive stimulation (newspaper, magazines, radio, television), early mobilisation, early enteral nutrition, early removal of drains or catheters, normalizing sleep-awake-rhythm.
Primary Outcome Measures
NameTimeMethod
postoperative cognitive deficit (POCD)change from baseline in cognitive function at day 7, 3 months and 1 year after operation

measured by neuropsychological test battery, analysis

Secondary Outcome Measures
NameTimeMethod
health related quality of life3 months, 1 year after operation

Short Form Health Survey (SF-12)

number of patients with respiratory complicationsday of operation until 7th postoperative day

daily documentation of pulmonary complications (pneumonia, pulmonary oedema, others),

number of patients with cardiac complicationsday of operation until 7th postoperative day

daily documentation of cardiac complications (central venous oxygen saturation, myocardial infarction, acute heart failure, others)

length of hospital stayfrom day of admission until day of discharge, up to 24 weeks
mortality1 year
number of patients with complications in the immunosystemday of operation until 7th postoperative day

daily documentation of parameters mirroring the immune answer (C-reactive protein, leukocytes, procalcitonin)

incidence and severity of postoperative deliriumfrom the day of operation until the 7th postoperative day

measured 3 times per day via CAM-ICU

number of patients with renal complicationsday of operation until 7th postoperative day

daily documentation of renal complications (creatinine, haemo(dia)filtration or haemodialysis)

Trial Locations

Locations (1)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Hamburg Eppendorf, Univ.-Prof. Dr. med. Alwin E. Goetz and Prof. Dr. med. Christian Zoellner

🇩🇪

Hamburg, Germany

© Copyright 2025. All Rights Reserved by MedPath